Effect of LM11A-31 in healthy volunteers

Trial Profile

Effect of LM11A-31 in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 05 May 2016

At a glance

  • Drugs LM 11A-31 (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 05 May 2016 According to PharmatrophiX company website, this study was completed during 2013-2014 and this study was supported by peer-reviewed funding from the ADDF, peer-reviewed funding by the Alzheimer's Association's Part-the-Cloud-Program, and by private investors.
    • 05 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top